Paul Capital Investor

Paul Capital was formed in 1991 as a pioneer in the secondary market, providing creative liquidity solutions to investors in private equity limited partnerships and portfolios of direct investments. In 1999, Paul Capital added its Healthcare Platform to invest in royalty and revenue interests in life science products. Today, Paul Capital sees the world from the vantage point of an experienced investor with unique insight and the ability to build compelling solutions for institutional investors. The team has grown to nearly 100 employees, with offices in Hong Kong, London, New York, Paris, San Francisco and São Paulo, managing a total of more than $6 billion across its distinct investment platforms.
Technology: N/A
Industry: Precision Medicine
Headquarters: Central, Hong Kong, China
Founded Date: 1991
Employees Number: 101-250
Funding Status: undisclosed
Investor Type: Secondary Purchaser
Investment Stage: Late Stage Venture, Private Equity
Number Of Exits: 4

Visit Website
Register and Claim Ownership